Farmaclair SAS
Farmaclair SAS, headquartered in France, is a prominent player in the pharmaceutical and biotechnology industry, specialising in the development and manufacturing of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Founded in 2005, the company has established a strong presence across Europe and beyond, focusing on innovative solutions that cater to the evolving needs of healthcare providers and patients. With a commitment to excellence, Farmaclair SAS offers a diverse range of products, including generic medicines and specialised formulations, distinguished by their rigorous quality standards and compliance with international regulations. The company has achieved significant milestones, positioning itself as a trusted partner in the pharmaceutical supply chain, renowned for its reliability and expertise in complex projects.
DitchCarbon Score
How does Farmaclair SAS's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Farmaclair SAS's score of 26 is lower than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Farmaclair SAS's reported carbon emissions
Farmaclair SAS, headquartered in France, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is identified as a current subsidiary and does not inherit emissions data from a parent organization. Consequently, there are no specific reduction targets or climate commitments documented, including those from the Science Based Targets initiative (SBTi) or other climate pledges. As a subsidiary, Farmaclair SAS may align with broader industry standards and practices regarding climate commitments, but specific initiatives or targets have not been disclosed. The lack of reported emissions data suggests an opportunity for the company to establish and communicate its climate strategy more effectively, particularly in the context of increasing global emphasis on sustainability and carbon footprint reduction.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Farmaclair SAS is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
